Sciclone Pharmaceuticals Inc
SCLN
SCLN was delisted on the 13th of October, 2017.
130 hedge funds and large institutions have $316M invested in Sciclone Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 17 closing their positions.
426% more call options, than puts
Call options by funds: $247K | Put options by funds: $47K
54% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 35
5% more capital invested
Capital invested by funds: $302M → $316M (+$14.7M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 131 → 130 (-1)
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$2.47M |
| 2 |
Millennium Management
New York
|
+$2.02M |
| 3 |
Renaissance Technologies
New York
|
+$1.92M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.47M |
| 5 |
SI
Sensato Investors
San Francisco,
California
|
+$1.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.52M |
| 2 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
-$2.43M |
| 3 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$1.9M |
| 4 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
-$1.85M |
| 5 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
-$1.42M |
SCLN Hedge Fund Activity: Q1 2015 in Review
130 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q1 2015, worth a combined $316M — up 4.9% from $302M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of SCLN and 16 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 54 added.
The largest buyer was Franklin Resources, adding an estimated $2.47M. The largest seller was Bogle Investment Management, cutting an estimated $2.52M.
- 130 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q1 2015, down from 131 in Q4 2014.
- Funds reported $316M of Sciclone Pharmaceuticals Inc stock for Q1 2015, up 4.9% quarter-over-quarter.
- 16 funds opened new Sciclone Pharmaceuticals Inc positions in Q1 2015 and 17 closed out, a net change of -1 holder.
- The largest Sciclone Pharmaceuticals Inc buyer in Q1 2015 was Franklin Resources, an estimated $2.47M added.
- The largest Sciclone Pharmaceuticals Inc seller in Q1 2015 was Bogle Investment Management, an estimated $2.52M sold.
Based on aggregated 13F filings for Q1 2015.